210 related articles for article (PubMed ID: 36161052)
1. Family-based
Yu XC; Shao QQ; Ma J; Yu M; Zhang C; Lei L; Zhou Y; Chen WC; Zhang W; Fang XH; Zhu YZ; Wu G; Wang XM; Han SY; Sun PC; Ding SZ
World J Gastroenterol; 2022 Jul; 28(28):3706-3719. PubMed ID: 36161052
[TBL] [Abstract][Full Text] [Related]
2. Type I and type II
Yuan L; Zhao JB; Zhou YL; Qi YB; Guo QY; Zhang HH; Khan MN; Lan L; Jia CH; Zhang YR; Ding SZ
World J Gastroenterol; 2020 Jul; 26(25):3673-3685. PubMed ID: 32742135
[TBL] [Abstract][Full Text] [Related]
3. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
Adamczyk M; Peczek Ł; Rudnicki C; Nawrot B; Stec-Michalska K
Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
[TBL] [Abstract][Full Text] [Related]
4. Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: a 1-year follow-up study.
Gisbert JP; Boixeda D; Al-Mostafa A; Vila T; de Rafael L; Alvarez Baleriola I; de Argila CM; Abraira V
Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):189-200. PubMed ID: 10102232
[TBL] [Abstract][Full Text] [Related]
5. Associations of Serum Pepsinogens and Helicobacter Pylori Infection with High-Sensitivity C-Reactive Protein in Medical Examination Population.
Liu H; Fei C; Zhang J
Lab Med; 2021 Jan; 52(1):57-63. PubMed ID: 32702129
[TBL] [Abstract][Full Text] [Related]
6. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
7. Changes with aging in gastric biomarkers levels and in biochemical factors associated with
Shan JH; Bai XJ; Han LL; Yuan Y; Sun XF
World J Gastroenterol; 2017 Aug; 23(32):5945-5953. PubMed ID: 28932086
[TBL] [Abstract][Full Text] [Related]
8. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
9. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori infection, serum pepsinogens, and pediatric abdominal pain: a pilot study.
Kassem E; Naamna M; Mawassy K; Beer-Davidson G; Muhsen K
Eur J Pediatr; 2017 Aug; 176(8):1099-1105. PubMed ID: 28681188
[TBL] [Abstract][Full Text] [Related]
11. Association between abnormal gastric function risk and Helicobacter pylori infection assessed by ELISA and 14C-urea breath test.
Gong Y; Wei W; Yuan Y
Diagn Microbiol Infect Dis; 2014 Dec; 80(4):316-20. PubMed ID: 25284372
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori, pepsinogens and gastrin: relationship with age and development of atrophic gastritis.
Kuipers EJ; Pals G; Peña AS; van Uffelen CW; Kok A; Westerveld BD; Meuwissen SG
Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):153-6. PubMed ID: 8723421
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of
Li CX; Wang XH; Ma ZQ; Zhan YH; Shen LJ; Wang F; Li YH
Zhonghua Nei Ke Za Zhi; 2024 Jan; 63(1):41-45. PubMed ID: 38186116
[No Abstract] [Full Text] [Related]
14. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.
Leja M; Cine E; Rudzite D; Vilkoite I; Huttunen T; Daugule I; Rumba-Rozenfelde I; Pimanov S; Liepniece-Karele I; Pahomova J; Purmalis K; Eglitis J; Pirags V; Dzerve V; Erglis A
Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1410-7. PubMed ID: 23114744
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection.
Kwon Y; Jeon S; Nam S; Shin I
Aliment Pharmacol Ther; 2017 Oct; 46(8):758-767. PubMed ID: 28799258
[TBL] [Abstract][Full Text] [Related]
16. Transmission of Helicobacter pylori infection. Studies in families of healthy individuals.
Malaty HM; Graham DY; Klein PD; Evans DG; Adam E; Evans DJ
Scand J Gastroenterol; 1991 Sep; 26(9):927-32. PubMed ID: 1947784
[TBL] [Abstract][Full Text] [Related]
17. Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies.
Hartleb M; Wandzel P; Waluga M; Matyszczyk B; Bołdys H; Romañczyk T
Acta Gastroenterol Belg; 2004; 67(4):320-6. PubMed ID: 15727075
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of
Fernandez-Botran R; Wellmann IA; Une C; Méndez-Chacón E; Hernández de Rodas E; Bhandari B; Villagrán de Tercero CI
Am J Trop Med Hyg; 2020 Jul; 103(1):260-265. PubMed ID: 32314688
[TBL] [Abstract][Full Text] [Related]
19. Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study.
Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Long Q; Flanders WD; Bostick RM; Yuan Y
Int J Cancer; 2015 Jan; 136(2):425-34. PubMed ID: 24895149
[TBL] [Abstract][Full Text] [Related]
20. Changes in gastrin and serum pepsinogens in monitoring of Helicobacter pylori response to therapy.
Pérez-Paramo M; Albillos A; Calleja JL; Salas C; Marín MC; Marcos ML; Cacho G; Escartín P; Ortiz-Berrocal J
Dig Dis Sci; 1997 Aug; 42(8):1734-40. PubMed ID: 9286242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]